Clinical Strategies for Including Severely Affected Individuals in Neuroscience Studies

SIG Leaders: Emily S. Kuschner, PhD; Christine Wu Nordahl, PhD; Mark D. Shen SIG Co-Leader: Kevin G. Stephenson, MS Returning SIG (formerly titled Clinical Strategies for Increasing Inclusion in Neuroscience Research Across the ASD Spectrum). Many severely affected children are excluded from neuroscience research due to the procedural demands of data collection with neuroimaging and electrophysiology technologies. Thus, our understanding of brain development in ASD is generally limited to only the “high functioning” children included in studies. SIG attendees will receive practical strategies to maximize successful, high quality data collection from individuals across the spectrum (e.g., how to lie still in the MRI scanner, or tolerate an EEG cap).